A new study suggests patients with darker skin types are more prone than those with lighter skin to acral pigmented lesions, and many people are unaware those lesions exist.
We’re looking back on what made the biggest impacts on dermatology in 2015. This is what your peers had to say.
Expert offers colleagues insight about the runner’s mentality on sunscreen and best practices for educating your local community
Transparent bioadhesive nanoparticles may offer alternative sun safety technology without the chemical exposure; questions remain
The ASDS, AAD, and other dermatology societies offer a wide variety of resources and programs that dermatologists can implement and get involved in to prevent skin cancer in their communities.
Survival rates for lentigo maligna (LM) melanoma-type melanomas vary. Acral lentiginous melanoma has a significantly worse survival rate than other melanoma subtypes with race appearing to play a role. Another factor may be poor awareness.
Lentigo maligna (LM) and acral lentiginous melanoma (ALM) can be challenging to diagnosis and treat, according to experts. Here, they offer insight into incidence, presentation, and management options. Learn more
It’s believed that viruses cause 15-20% of all cancer cases worldwide. New technologies have helped illuminate hundreds of new viruses and researchers are only beginning to understand how those resident in the skin may cause dermatologic disorders
In the treatment of non-melanoma skin cancer, “the fastest-moving area—and the neatest from a science standpoint—is the class of drugs called hedgehog pathway inhibitors.”
Clinicians agree that multi-disciplinary teams are the optimal approach to managing advanced melanoma, for they aim for consistent messaging to patients about treatment and require that physicians who are members of the team support their therapeutic choices with evidence. However, obstacles include geographical challenges in community care, treatment sequencing and bias, and physician communication.